Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 121 (RPL21P121)

Target: RPL21P121
Molecular classification: Pseudogene

Overview

RPL21P121, or ribosomal protein L21 pseudogene 121, is a processed pseudogene related to the RPL21 gene, which encodes 60S ribosomal protein L21, a component of the large ribosomal subunit involved in protein synthesis. Pseudogenes like RPL21P121 do not encode functional proteins, are not involved in cellular biological processes, and are not considered therapeutic targets. They are typically the result of gene duplication or retrotransposition events and are dispersed throughout the genome[2][7].

Other names: RPL21_56_1523

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 121 (RPL21P121).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 121 (RPL21P121).

Explore the full profile